Bleeding patterns after vaginal misoprostol for treatment of early pregnancy failure

• Published in: Human reproduction (Oxford) Vol. 19; no. 7; pp. 1655 - 1658
• Main Authors: Davis, A.R., Robilotto, C.M., Westhoff, C.L., Forman, S., Zhang, J.
• Format: Journal Article
• Language: English
• Published: Oxford Oxford University Press 01.07.2004; Oxford Publishing Limited (England)
• Subjects: Abortifacient Agents, Nonsteroidal - administration & dosage; Abortifacient Agents, Nonsteroidal - adverse effects; Abortion, Incomplete - drug therapy; Administration, Intravaginal; Adult; Biological and medical sciences; bleeding/early pregnancy failure/misoprostol; Embryology: invertebrates and vertebrates. Teratology; Female; Fundamental and applied biological sciences. Psychology; Hemoglobins - metabolism; Humans; Medical Records; Misoprostol - administration & dosage; Misoprostol - adverse effects; Pregnancy; Pregnancy Complications - drug therapy; Pregnancy Trimester, First; Time Factors; Uterine Hemorrhage - blood; Uterine Hemorrhage - chemically induced; Uterine Hemorrhage - physiopathology; bleeding/early pregnancy failure/misoprostol; Vertebrata; Mammalia; Treatment; Antisecretory agent; Early pregnancy; Antiulcer agent; Hemorrhage; Misoprostol; Failure; Prostaglandin derivatives

BACKGROUND: Dilatation and curettage (D&C) has been the usual treatment for early pregnancy failure (EPF). Medical management with misoprostol may be an effective alternative. Bleeding patterns during and after medical management of EPF are unknown. METHODS: A prospective cohort study was conduc...